PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Lederle ×

UPDATED
Regulatorische Updates
19. Sept. 2026•1 Min. Lesezeit
FDA NDA006920: Lederle's Triple Sulfas Oral Products Listed as Discontinued
The FDA’s NDA006920 for Lederle’s oral drug Triple Sulfas includes two discontinued formulations—a suspension and a tablet—both containing trisulfapyrimidines, sulfamerazine, and sulfamethazine.
UPDATED
Regulatorische Updates
25. Aug. 2026•1 Min. Lesezeit
FDA Approves ANDA086746 for Amitriptyline Tablet – Lederle
FDA approved application ANDA086746 for an oral amitriptyline hydrochloride 25 mg tablet submitted by Lederle; the product is listed as discontinued.
1